Post-COVID-19 Myelitis Manifesting as Partial Brown-Séquard Syndrome

Authors

DOI:

https://doi.org/10.46531/sinapse/CC/210074/2022

Keywords:

COVID-19/complications, Myelitis, Transverse, SARS-CoV-2

Abstract

Myelitis is a rare neurological complication of COVID-19. We will describe a patient with post-COVID-19 myelitis manifesting as partial Brown-Séquard syndrome. A 33-year-old male presented with progressive weakness of the lower limbs, evolving over the previous week. Six weeks before, the patient had had COVID-19, from which he had already recovered. Neurological examination revealed right lower limb weakness and reduced pain sensation on the left lower limb, with a T5-T6 sensory level. Thoracic magnetic resonance imaging (MRI) revealed a right intra-medullary lesion spanning from T3 to T4 with T2 signal hyperintensity. Cerebrospinal fluid study was normal, and SARS-CoV-2 was undetected. After excluding active infection, the patient received methylprednisolone and the symptoms improved. One month later, the neurological exam was considered normal and there was a significant lesion reduction on MRI. SARS-CoV-2 infection should be considered as a possible aetiology for myelitis in all patients, even in those with mild infection or asymptomatic.

Downloads

Download data is not yet available.

References

Ellul M, Benjamin L, Singh B, Lant S, Michael B, Easton A, et al. Neurological associations of COVID-19. Lancet Neurol. 2020; 19: 767-83. doi: 10.1016/S1474-4422(20)30221-0.

Nepal G, Rehrig J, Shrestha G, Shing Y, Yadav J, Ojha R, et al. Neurological manifestations of COVID-19: a systematic review. Crit Care. 2020; 24:421. doi: 10.1186/s13054-020-03121-z.

Román G, Gracia F, Torres A, Palacios A, Gracia K, Harris D. Acute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV19 Vaccine (AZD1222). Front Immunol. 2021; 26:653786. doi: 10.3389/fimmu.2021.653786.

Blackburn K, Wang C. Post-infectious neurological disorders. Ther Adv Neurol Disord. 2020; 13: 1-17. doi: 10.1177/1756286420952901

Chow C, Magnussen J, Lp J, Su Y. Acute transverse myelitis in COVID-19 infection. BMJ Case Rep. 2020; ;13:e236720. doi: 10.1136/bcr-2020-236720.

Munz M, Wessendorf S, Koretsis G, Tewald F, Baegi R, Kramer S, et al. Acute transverse myelitis after COVID-19 pneumonia. J Neurology. 2020: 267:2196-7. doi: 10.1007/ s00415-020-09934-w.

Zhao K, Huang J, Dai D, Feng Y, Liu L, Nie S. Acute myelitis after SARS-CoV-2 infection: a case report. medRxiv preprint. 2020. doi:10.1101/2020.03.16.20035105.

Garg R, Paliwal V, Gupta A. Spinal cord involvement in COVID-19: a review. J Spinal Cord Med. 2021: 1-15. doi: 10.1080/10790268.2021.1888022.

Kara S, Candelore T, Youssef P, Nedd K. Evidence of Post-COVID-19 Transverse Myelitis Demyelination. Cureus. 13(10). doi:10.7759/cureus.19087

Downloads

Published

2024-04-20

How to Cite

1.
Silva C, Lima AC, Santana I, Batista S. Post-COVID-19 Myelitis Manifesting as Partial Brown-Séquard Syndrome. Sinapse [Internet]. 2024 Apr. 20 [cited 2024 Nov. 21];22(1):34-7. Available from: https://sinapse.pt/index.php/journal/article/view/76

Issue

Section

Case Reports

Most read articles by the same author(s)